Clinical Trial Update: Molecular Analysis of Microphthalmia/Anophthalmia

View source ↗

Summary

The NHGRI-sponsored study on microphthalmia and anophthalmos has completed and reports molecular-analysis findings for these conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anophthalmos
• Microphthalmia

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Anophthalmos | Status: COMPLETED